Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.

@article{Nautiyal2011CurcuminED,
  title={Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.},
  author={Jyoti Nautiyal and S Preeya Banerjee and Shailender Singh Kanwar and Yingjie Yu and Bhaumik B. Patel and Fazlul H. Sarkar and Adhip P. N. Majumdar},
  journal={International journal of cancer},
  year={2011},
  volume={128 4},
  pages={951-61}
}
Colorectal cancer is the third most common form of malignancy, behind prostate and lung cancers. Despite recent advances in medicine, mortality from colorectal cancer remains high, highlighting the need for improved therapies. Numerous studies have demonstrated increased activation of EGFR and its family members (EGFRs), IGF-1R as well as c-Src in colorectal cancer. The current study was undertaken to examine the effectiveness of combination therapy of dasatinib (BMS-354825; Bristol-Myers… CONTINUE READING
36 Citations
55 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 55 references

Targeting Src family kinases inhibits growth and lymph C an ce r T he ra py 960 Curcumin and dasatinib in colon cancer

  • SI Park, J Zhang, +7 authors GE. Gallick
  • Int. J. Cancer:
  • 2011

Similar Papers

Loading similar papers…